Literature DB >> 21886746

Childhood linear IgA bullous disease induced by trimethoprim-sulfamethoxazole.

Mélissa Nantel-Battista1, Rola Al Dhaybi, Afshin Hatami, Danielle Marcoux, Anne Desroches, Victor Kokta.   

Abstract

BACKGROUND: Linear IgA bullous disease (LABD) is a rare mucocutaneous autoimmune subepidermal blistering disease that can affect children mostly of pre-school age. As many as two-thirds of LABD are related to drug ingestion, particularly certain antibiotics, non-steroidal anti-inflammatory drugs and diuretics. MAIN OBSERVATION: We describe a 3-year-old boy who presented a CMV infection followed by LABD induced by trimtheporim-sulfametoxazole. To our knowledge, this is the first reported case of trimethoprim-sulfamethoxazole that was confirmed by a rechallenge.
CONCLUSIONS: Most cases of drug-induced LABD are patients being treated with multiple systemic drugs that could induce the LABD. In the lack of suitable alternative treatment, the identification of the causative drug can be achieved by a rechallenge under close medical surveillance.

Entities:  

Keywords:  LABD; autoimmune bullous disease; childhood; drug-induced; linear IgA bullous disease; trimethoprim-sulfamethoxazole

Year:  2010        PMID: 21886746      PMCID: PMC3157814          DOI: 10.3315/jdcr.2010.1053

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  11 in total

Review 1.  Linear IgA bullous dermatosis.

Authors:  C A Egan; J J Zone
Journal:  Int J Dermatol       Date:  1999-11       Impact factor: 2.736

2.  Childhood linear IgA disease in association with autoimmune lymphoproliferative syndrome.

Authors:  C S M Wong; P D Arkwright; F Rieux-Laucat; A J Cant; R F Stevens; M R Judge
Journal:  Br J Dermatol       Date:  2004-03       Impact factor: 9.302

Review 3.  Drug-induced linear immunoglobulin-A bullous dermatosis.

Authors:  M Camilleri; J L Pace
Journal:  Clin Dermatol       Date:  1998 May-Jun       Impact factor: 3.541

4.  Drug-induced linear IgA bullous disease following antibiotics.

Authors:  T P Wiadrowski; C M Reid
Journal:  Australas J Dermatol       Date:  2001-08       Impact factor: 2.875

5.  Drug-induced linear IgA disease: target antigens are heterogeneous.

Authors:  C Paul; P Wolkenstein; C Prost; F Caux; G Rostoker; M Heller; J Wechsler; J Revuz; J C Roujeau
Journal:  Br J Dermatol       Date:  1997-03       Impact factor: 9.302

Review 6.  Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children.

Authors:  Edward Karpman; Eric A Kurzrock
Journal:  J Urol       Date:  2004-08       Impact factor: 7.450

7.  Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid.

Authors:  Jean Chin Ching Ho; Pei Lin Patricia Ng; Suat Hoon Tan; Yoke Chin Giam
Journal:  Pediatr Dermatol       Date:  2007 Sep-Oct       Impact factor: 1.588

8.  Amoxicillin-clavulanic acid-induced linear immunoglobulin A bullous dermatosis: case report and review of the literature.

Authors:  Vincenzo Panasiti; Mariarita Rossi; Valeria Devirgiliis; Michela Curzio; Ugo Bottoni; Stefano Calvieri
Journal:  Int J Dermatol       Date:  2009-09       Impact factor: 2.736

9.  Chronic bullous disease of childhood in a patient with acute lymphoblastic leukemia: possible induction by a drug.

Authors:  Muhterem Polat; Nurdan Lenk; Emin Kürekçi; Pinar Oztaş; Ferda Artüz; Nuran Alli
Journal:  Am J Clin Dermatol       Date:  2007       Impact factor: 7.403

Review 10.  Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature.

Authors:  M K Kuechle; E Stegemeir; B Maynard; L E Gibson; K M Leiferman; M S Peters
Journal:  J Am Acad Dermatol       Date:  1994-02       Impact factor: 11.527

View more
  6 in total

1.  Not all that blisters is infectious.

Authors:  Rosalind Ashton; Caroline Mahon
Journal:  Can Fam Physician       Date:  2022-04       Impact factor: 3.275

2.  Drug-induced linear IgA bullous dermatosis after discontinuation of cefuroxime axetil treatment.

Authors:  Maciej Pastuszczak; Sylwia Lipko-Godlewska; Andrzej K Jaworek; Anna Wojas-Pelc
Journal:  J Dermatol Case Rep       Date:  2012-12-31

Review 3.  Bullous Diseases in Children: A Review of Clinical Features and Treatment Options.

Authors:  Brittney Schultz; Kristen Hook
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

Review 4.  Cutaneous drug reactions in children: an update.

Authors:  Kara Heelan; Neil H Shear
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

Review 5.  Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity.

Authors:  Katherine C Konvinse; Elizabeth J Phillips; Katie D White; Jason A Trubiano
Journal:  Curr Opin Infect Dis       Date:  2016-12       Impact factor: 4.915

Review 6.  Linear Immunoglobulin a Bullous Dermatosis in Children.

Authors:  Francesca Mori; Francesca Saretta; Lucia Liotti; Mattia Giovannini; Riccardo Castagnoli; Stefania Arasi; Simona Barni; Carla Mastrorilli; Luca Pecoraro; Lucia Caminiti; Gian Luigi Marseglia; Annick Barbaud; Elio Novembre
Journal:  Front Pediatr       Date:  2022-07-08       Impact factor: 3.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.